Click here to get full coverage on Medical tech company sets Jan. 6 call to share latest quarter - Stock Titan

Medical tech company sets Jan. 6 call to share latest quarter  Stock Titan

Medical tech company sets Jan. 6 call to share latest quarter - Stock Titan

Click here to get full coverage on Discipline and Rules-Based Execution in ANGO Response - news.stocktradersdaily.com

Discipline and Rules-Based Execution in ANGO Response  news.stocktradersdaily.com

Discipline and Rules-Based Execution in ANGO Response - news.stocktradersdaily.com

Click here to get full coverage on AngioDynamics (ANGO): Losses Worsen, but Forecasted 62% Earnings Growth Challenges Bearish Narratives - Yahoo Finance

AngioDynamics (ANGO): Losses Worsen, but Forecasted 62% Earnings Growth Challenges Bearish Narratives  Yahoo Finance

AngioDynamics (ANGO): Losses Worsen, but Forecasted 62% Earnings Growth Challenges Bearish Narratives - Yahoo Finance

Click here to get full coverage on Obsidian’s CEO on why productivity tools need community more than AI - The Verge

Obsidian’s CEO on why productivity tools need community more than AI  The Verge

Obsidian’s CEO on why productivity tools need community more than AI - The Verge

Click here to get full coverage on ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - Zacks Investment Research

ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves  Zacks Investment Research

ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - Zacks Investment Research

Click here to get full coverage on AngioDynamics Stock (ANGO) Opinions on CEO Share Purchase | ANGO Stock News - Quiver Quantitative

AngioDynamics Stock (ANGO) Opinions on CEO Share Purchase | ANGO Stock News  Quiver Quantitative

AngioDynamics Stock (ANGO) Opinions on CEO Share Purchase | ANGO Stock News - Quiver Quantitative

Click here to get full coverage on New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan

New York medtech firm to present at J.P. Morgan healthcare conference  Stock Titan

New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan

Click here to get full coverage on Pre-Market Earnings Report for October 2, 2025 : ANGO - Nasdaq

Pre-Market Earnings Report for October 2, 2025 : ANGO  Nasdaq

Pre-Market Earnings Report for October 2, 2025 : ANGO - Nasdaq

Click here to get full coverage on AngioDynamics (NASDAQ:ANGO) Reaches New 1-Year High - What's Next? - MarketBeat

AngioDynamics (NASDAQ:ANGO) Reaches New 1-Year High - What's Next?  MarketBeat

AngioDynamics (NASDAQ:ANGO) Reaches New 1-Year High - What's Next? - MarketBeat

Click here to get full coverage on Angiodynamics (ANGO) CEO Clemmer buys $111,500 in shares - Investing.com

Angiodynamics (ANGO) CEO Clemmer buys $111,500 in shares  Investing.com

Angiodynamics (ANGO) CEO Clemmer buys $111,500 in shares - Investing.com

Click here to get full coverage on AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year - Yahoo Finance

AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year  Yahoo Finance

AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year - Yahoo Finance

Click here to get full coverage on AngioDynamics Stock (ANGO) Opinions on Congressional Stock Sale - Quiver Quantitative

AngioDynamics Stock (ANGO) Opinions on Congressional Stock Sale  Quiver Quantitative

AngioDynamics Stock (ANGO) Opinions on Congressional Stock Sale - Quiver Quantitative

Click here to get full coverage on Armistice Capital LLC Sells 566,185 Shares of AngioDynamics, Inc. $ANGO - MarketBeat

Armistice Capital LLC Sells 566,185 Shares of AngioDynamics, Inc. $ANGO  MarketBeat

Armistice Capital LLC Sells 566,185 Shares of AngioDynamics, Inc. $ANGO - MarketBeat

Click here to get full coverage on AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance

AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Insider Purchase: SVP of $ANGO Buys 10,000 Shares | ANGO Stock News - Quiver Quantitative

Insider Purchase: SVP of $ANGO Buys 10,000 Shares | ANGO Stock News  Quiver Quantitative

Insider Purchase: SVP of $ANGO Buys 10,000 Shares | ANGO Stock News - Quiver Quantitative

Click here to get full coverage on AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen - MarketBeat

AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen  MarketBeat

AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Click here to get full coverage on ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines - Yahoo Finance

ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines  Yahoo Finance

ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines - Yahoo Finance

Click here to get full coverage on Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result - Yahoo Finance

Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result  Yahoo Finance

Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result - Yahoo Finance

Click here to get full coverage on $ANGO stock is up 3% today. Here's what we see in our data. - Quiver Quantitative

$ANGO stock is up 3% today. Here's what we see in our data.  Quiver Quantitative

$ANGO stock is up 3% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates  Yahoo Finance

AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings - Yahoo Finance

What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings  Yahoo Finance

What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings - Yahoo Finance

Click here to get full coverage on AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... - Yahoo Finance

AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ...  Yahoo Finance

AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... - Yahoo Finance

Click here to get full coverage on What drives ANGO stock price - Low Risk Investment Ideas & Buy Sell Signal Notifications - earlytimes.in

What drives ANGO stock price - Low Risk Investment Ideas & Buy Sell Signal Notifications  earlytimes.in

What drives ANGO stock price - Low Risk Investment Ideas & Buy Sell Signal Notifications - earlytimes.in

Click here to get full coverage on AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha

AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO)  Seeking Alpha

AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha

Click here to get full coverage on Is ANGO a good long term investment - Institutional Holding Changes & Grow Steadily With Our Wealth Roadmap - earlytimes.in

Is ANGO a good long term investment - Institutional Holding Changes & Grow Steadily With Our Wealth Roadmap  earlytimes.in

Is ANGO a good long term investment - Institutional Holding Changes & Grow Steadily With Our Wealth Roadmap - earlytimes.in

Click here to get full coverage on AngioDynamics (NASDAQ:ANGO) Hits New 1-Year High - What's Next? - MarketBeat

AngioDynamics (NASDAQ:ANGO) Hits New 1-Year High - What's Next?  MarketBeat

AngioDynamics (NASDAQ:ANGO) Hits New 1-Year High - What's Next? - MarketBeat

Click here to get full coverage on (ANGO) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

(ANGO) Movement Within Algorithmic Entry Frameworks  news.stocktradersdaily.com

(ANGO) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Click here to get full coverage on AngioDynamics: A MedTech Powerhouse Emerging From Legacy Overhaul (NASDAQ:ANGO) - Seeking Alpha

AngioDynamics: A MedTech Powerhouse Emerging From Legacy Overhaul (NASDAQ:ANGO)  Seeking Alpha

AngioDynamics: A MedTech Powerhouse Emerging From Legacy Overhaul (NASDAQ:ANGO) - Seeking Alpha

Click here to get full coverage on AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan

AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET  Stock Titan

AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan

Click here to get full coverage on Is ANGO stock attractive for ETFs - 2025 Major Catalysts & Intraday High Probability Setup Alerts - Улправда

Is ANGO stock attractive for ETFs - 2025 Major Catalysts & Intraday High Probability Setup Alerts  Улправда

Is ANGO stock attractive for ETFs - 2025 Major Catalysts & Intraday High Probability Setup Alerts - Улправда

Click here to get full coverage on AngioDynamics (ANGO) Updates FY26 Revenue and EPS Projections - GuruFocus

AngioDynamics (ANGO) Updates FY26 Revenue and EPS Projections  GuruFocus

AngioDynamics (ANGO) Updates FY26 Revenue and EPS Projections - GuruFocus

Click here to get full coverage on Why ANGO stock is recommended by analysts - Weekly Stock Analysis & Expert Verified Stock Movement Alerts - Улправда

Why ANGO stock is recommended by analysts - Weekly Stock Analysis & Expert Verified Stock Movement Alerts  Улправда

Why ANGO stock is recommended by analysts - Weekly Stock Analysis & Expert Verified Stock Movement Alerts - Улправда

Click here to get full coverage on AngioDynamics (ANGO) Stock Surges 10% on Earnings Beat - GuruFocus

AngioDynamics (ANGO) Stock Surges 10% on Earnings Beat  GuruFocus

AngioDynamics (ANGO) Stock Surges 10% on Earnings Beat - GuruFocus

Click here to get full coverage on Will ANGO stock benefit from automation - Market Growth Summary & Daily Price Action Insights - Улправда

Will ANGO stock benefit from automation - Market Growth Summary & Daily Price Action Insights  Улправда

Will ANGO stock benefit from automation - Market Growth Summary & Daily Price Action Insights - Улправда

Click here to get full coverage on Is ANGO stock attractive for ETFs - 2025 Institutional Moves & AI Optimized Trading Strategy Guides - Улправда

Is ANGO stock attractive for ETFs - 2025 Institutional Moves & AI Optimized Trading Strategy Guides  Улправда

Is ANGO stock attractive for ETFs - 2025 Institutional Moves & AI Optimized Trading Strategy Guides - Улправда

Click here to get full coverage on Will ANGO stock gain from strong economy - Analyst Downgrade & Entry Point Confirmation Alerts - Улправда

Will ANGO stock gain from strong economy - Analyst Downgrade & Entry Point Confirmation Alerts  Улправда

Will ANGO stock gain from strong economy - Analyst Downgrade & Entry Point Confirmation Alerts - Улправда

Click here to get full coverage on AngioDynamics (ANGO) Surges 10% Following Strong Q4 Earnings | A - GuruFocus

AngioDynamics (ANGO) Surges 10% Following Strong Q4 Earnings | A  GuruFocus

AngioDynamics (ANGO) Surges 10% Following Strong Q4 Earnings | A - GuruFocus

Click here to get full coverage on Wike boots out FCT-IRS acting chairman Michael Ango - MSN

Wike boots out FCT-IRS acting chairman Michael Ango  MSN

Wike boots out FCT-IRS acting chairman Michael Ango - MSN

Click here to get full coverage on AngioDynamics (ANGO): Forecast 62% Annual Earnings Growth as Investors Eye Turn to Profitability - simplywall.st

AngioDynamics (ANGO): Forecast 62% Annual Earnings Growth as Investors Eye Turn to Profitability  simplywall.st

AngioDynamics (ANGO): Forecast 62% Annual Earnings Growth as Investors Eye Turn to Profitability - simplywall.st

Click here to get full coverage on Will ANGO stock benefit from automation - July 2025 Earnings & Low Volatility Stock Recommendations - Улправда

Will ANGO stock benefit from automation - July 2025 Earnings & Low Volatility Stock Recommendations  Улправда

Will ANGO stock benefit from automation - July 2025 Earnings & Low Volatility Stock Recommendations - Улправда

Click here to get full coverage on Wike sacks acting FCT-IRS chairman Michael Ango - Business News Nigeria

Wike sacks acting FCT-IRS chairman Michael Ango  Business News Nigeria

Wike sacks acting FCT-IRS chairman Michael Ango - Business News Nigeria

Click here to get full coverage on Will ANGO stock deliver shareholder value - July 2025 Outlook & AI Forecasted Stock Moves - Улправда

Will ANGO stock deliver shareholder value - July 2025 Outlook & AI Forecasted Stock Moves  Улправда

Will ANGO stock deliver shareholder value - July 2025 Outlook & AI Forecasted Stock Moves - Улправда

Click here to get full coverage on ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - TradingView — Track All Markets

ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves  TradingView — Track All Markets

ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - TradingView — Track All Markets

Click here to get full coverage on Why AngioDynamics Stock Popped, Then Dropped Today - The Motley Fool

Why AngioDynamics Stock Popped, Then Dropped Today  The Motley Fool

Why AngioDynamics Stock Popped, Then Dropped Today - The Motley Fool

Click here to get full coverage on Insider Stock Purchases: October 22, 2025 - Quiver Quantitative

Insider Stock Purchases: October 22, 2025  Quiver Quantitative

Insider Stock Purchases: October 22, 2025 - Quiver Quantitative

Click here to get full coverage on H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance - Insider Monkey

H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance  Insider Monkey

H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance - Insider Monkey

Click here to get full coverage on AngioDynamics Stock (ANGO): Surges on Med-Tech Growth, Raises Outlook - Value The Markets

AngioDynamics Stock (ANGO): Surges on Med-Tech Growth, Raises Outlook  Value The Markets

AngioDynamics Stock (ANGO): Surges on Med-Tech Growth, Raises Outlook - Value The Markets

Click here to get full coverage on Foundation supports Bauchi Christians at Yuletide - The Guardian Nigeria News

Foundation supports Bauchi Christians at Yuletide  The Guardian Nigeria News

Foundation supports Bauchi Christians at Yuletide - The Guardian Nigeria News

Click here to get full coverage on AngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

AngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...  Yahoo Finance

AngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Click here to get full coverage on Shakshouka w/ Ango 14th May 2025 - NTS Radio

Shakshouka w/ Ango 14th May 2025  NTS Radio

Shakshouka w/ Ango 14th May 2025 - NTS Radio

Click here to get full coverage on Insider Buying: Lawrence Weiss Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus

Insider Buying: Lawrence Weiss Acquires Shares of AngioDynamics Inc (ANGO)  GuruFocus

Insider Buying: Lawrence Weiss Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus

Click here to get full coverage on Wike Reinstates Education Mandate Secretary, IRS Acting Chairman - Channels Television

Wike Reinstates Education Mandate Secretary, IRS Acting Chairman  Channels Television

Wike Reinstates Education Mandate Secretary, IRS Acting Chairman - Channels Television

Click here to get full coverage on AngioDynamics Inc. (ANGO) reports earnings - qz.com

AngioDynamics Inc. (ANGO) reports earnings  qz.com

AngioDynamics Inc. (ANGO) reports earnings - qz.com

Click here to get full coverage on AngioDynamics CEO, President & Director Acquires 1.9% More Stock - simplywall.st

AngioDynamics CEO, President & Director Acquires 1.9% More Stock  simplywall.st

AngioDynamics CEO, President & Director Acquires 1.9% More Stock - simplywall.st

Click here to get full coverage on Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results - Benzinga

Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results  Benzinga

Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results - Benzinga

Click here to get full coverage on Wike reinstates two suspended FCT officials, vows zero tolerance for indiscipline - Punch Newspapers

Wike reinstates two suspended FCT officials, vows zero tolerance for indiscipline  Punch Newspapers

Wike reinstates two suspended FCT officials, vows zero tolerance for indiscipline - Punch Newspapers

Click here to get full coverage on Weiss, AngioDynamics SVP, buys $118,100 in ANGO stock By Investing.com - Investing.com India

Weiss, AngioDynamics SVP, buys $118,100 in ANGO stock By Investing.com  Investing.com India

Weiss, AngioDynamics SVP, buys $118,100 in ANGO stock By Investing.com - Investing.com India

Click here to get full coverage on Wike sacks FCT-IRS acting chair — weeks after staff honoured him for exemplary leadership - TheCable

Wike sacks FCT-IRS acting chair — weeks after staff honoured him for exemplary leadership  TheCable

Wike sacks FCT-IRS acting chair — weeks after staff honoured him for exemplary leadership - TheCable

Click here to get full coverage on iMerit Unveils Ango Hub Deep Reasoning Lab for GenAI - Yahoo Finance

iMerit Unveils Ango Hub Deep Reasoning Lab for GenAI  Yahoo Finance

iMerit Unveils Ango Hub Deep Reasoning Lab for GenAI - Yahoo Finance

Click here to get full coverage on Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - August 21, 2025 - Zacks Investment Research

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - August 21, 2025  Zacks Investment Research

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - August 21, 2025 - Zacks Investment Research

Click here to get full coverage on CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $17 - 富途牛牛

CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $17  富途牛牛

CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $17 - 富途牛牛

Click here to get full coverage on Ango Sakaguchi Exhibition （Jissen Women's University Shibuya Campus） - Tokyo Art Beat

Ango Sakaguchi Exhibition （Jissen Women's University Shibuya Campus）  Tokyo Art Beat

Ango Sakaguchi Exhibition （Jissen Women's University Shibuya Campus） - Tokyo Art Beat

Click here to get full coverage on Will ANGO stock gain from strong economy - 2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - Улправда

Will ANGO stock gain from strong economy - 2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas  Улправда

Will ANGO stock gain from strong economy - 2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - Улправда

Click here to get full coverage on AngioDynamics (ANGO) Exceeds Q3 Expectations, Raises Fiscal 2025 Guidance - GuruFocus

AngioDynamics (ANGO) Exceeds Q3 Expectations, Raises Fiscal 2025 Guidance  GuruFocus

AngioDynamics (ANGO) Exceeds Q3 Expectations, Raises Fiscal 2025 Guidance - GuruFocus

Click here to get full coverage on Wike sacks FCT-IRS acting chair - Punch Newspapers

Wike sacks FCT-IRS acting chair  Punch Newspapers

Wike sacks FCT-IRS acting chair - Punch Newspapers

Click here to get full coverage on Ango Abdullahi's son, who won PDP house of reps' ticket while in captivity, resigns from party - TheCable

Ango Abdullahi's son, who won PDP house of reps' ticket while in captivity, resigns from party  TheCable

Ango Abdullahi's son, who won PDP house of reps' ticket while in captivity, resigns from party - TheCable

Click here to get full coverage on In loving memory of Ruqayyah Ali Ango: A light of kindness and grace, By Hadiza Adamu Fika - Premium Times Nigeria

In loving memory of Ruqayyah Ali Ango: A light of kindness and grace, By Hadiza Adamu Fika  Premium Times Nigeria

ANGO

Price Chart

Key Statistics

Technicals

About ANGO

Latest News

Medical tech company sets Jan. 6 call to share latest quarter - Stock Titan

Discipline and Rules-Based Execution in ANGO Response - news.stocktradersdaily.com

AngioDynamics (ANGO): Losses Worsen, but Forecasted 62% Earnings Growth Challenges Bearish Narratives - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers